APVO
Aptevo Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.84
+0.00%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$3.71
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$5.31
- EPS estimate
- -$6.02
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$6.02 | -$5.31 | Beat 11.79% | — |
| May 13, 2026 | -$5.60 | -$6.41 | Miss -14.46% | — |
| Nov 6, 2025 | -$38 | -$40 | Miss -6.70% | — |
| May 15, 2025 | -$1.5K | -$1.6K | Miss -4.28% | — |
| Mar 4, 2025 | -$7.75 | -$82 | Miss -962.84% | — |
| Nov 7, 2024 | -$7.4K | -$6.3K | Beat 15.79% | — |
| Aug 8, 2024 | -$25.2K | -$21.8K | Beat 13.47% | — |
| Mar 5, 2024 | -$18 | -$6.16 | Beat 65.85% | — |
| Nov 14, 2023 | -$413.4K | -$287.1K | Beat 30.56% | — |
| Aug 10, 2023 | -$643.0K | -$706.2K | Miss -9.82% | — |
| May 11, 2023 | -$683.2K | $149.3K | Beat 121.85% | — |
| Nov 10, 2022 | -$941.6K | -$878.4K | Beat 6.71% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026